The Buzz of BIO contest provides an excellent opportunity for companies looking to make the connections needed to take their product to the next phase. Ten biotechs will be nominated in each of the three categories: Early Stage Entrepreneur, Late Stage Leader, and Diagnostics and Beyond. Please note that the contest is open to U.S. companies only.
There are two phases to the Buzz of BIO Contest: Nominations and Voting.
During the nominations period, August 24 - September 4, we will collect nominations and review them to ensure they qualify for one of the three categories listed above, and that they meet the guidelines outlined in the contest rules here.
During the voting period, September 15 - 17, nominees are encouraged to promote their participation in the contest via social media, email, etc.
The companies with the most number of votes in each category at the end of the voting period will win a complimentary conference registration and company presentation, along with exposure to thousands of industry elites and potential investors.
Read the official contest rules here.
Companies must be actively developing a therapeutic product intended for FDA review that addresses human health issues and have raised less than $25 million USD as of July 1, 2019; have been founded after 2016; and have most recently completed either a Seed or Series A financing round.
Companies must be actively developing a therapeutic product intended for FDA review that addresses human health issues and have raised more than $25 million USD as of July 1, 2019 and have enrolled at least one patient in a company-sponsored clinical trial posted at https://clinicaltrials.gov.
Companies must be primarily focused in medical diagnostics, drug delivery, drug development tools, or digital health technologies.